Browsing: testosterone deficiency

Shah, whose company developed the oral testosterone drug Kyzatrex, urged regulators to broaden treatment access and align policy with modern science and preventive healthcare goals.

Kyzatrex could be a potential blockbuster to treat testosterone deficiency, a severely undertreated disease.